Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial.

Jason Charles RayZhibin ChenGeorgia RamsayJack GermaineElspeth J Hutton

Published in: BMJ open (2022)

The trial registration number is ACTRN12621001616864. The results of this study will be disseminated through peer-reviewed journals, conference presentations and social media.

Keyphrases

social media
health information
study protocol
clinical trial
mental health
palliative care
phase iii
healthcare
phase ii
replacement therapy